COVID-19 vaccines (revisited) and oral-mucosal vector system as a potential vaccine platform
There are several emerging strategies for the vaccination of COVID-19 (SARS-CoV-2)
however, only a few have yet shown promising effects. Thus, choosing the right pathway and …
however, only a few have yet shown promising effects. Thus, choosing the right pathway and …
[HTML][HTML] Mucosal COVID-19 vaccines: Risks, benefits and control of the pandemic
D Miteva, M Peshevska-Sekulovska… - World Journal of …, 2022 - ncbi.nlm.nih.gov
Based on mucosal immunization to promote both mucosal and systemic immune responses,
next-generation coronavirus disease 2019 (COVID-19) vaccines would be administered …
next-generation coronavirus disease 2019 (COVID-19) vaccines would be administered …
[HTML][HTML] CTLs 相关的免疫疗法在肝癌治疗中的新前景
许佐明， 浦涧 - 世界华人消化杂志, 2017 - wjgnet.com
癌细胞内多种蛋白加工处理所产生的异常多肽通过主要组织相容性复合物Ⅰ 类分子递呈,
激发肿瘤细胞毒性T 淋巴细胞(cytotoxic T lymphocytes, CTLs), 从而对肿瘤产生免疫作用 …
激发肿瘤细胞毒性T 淋巴细胞(cytotoxic T lymphocytes, CTLs), 从而对肿瘤产生免疫作用 …
[HTML][HTML] CTP-HBcAg18-27-Tapasin 诱导C57BL/6 小鼠HBV 特异性CTL 反应的机制
吴姗姗， 唐余燕， 王洁玲， 陈小华， 张毅， 汤正好… - 世界华人消化 …, 2016 - wjgnet.com
CTP-HBcAg18-27-Tapasin诱导C57BL/6小鼠HBV特异性CTL反应的机制 主页 简体中文 English
简体中文 登录 BPG Management System F6Publishing-Submit a Manuscript F6Publishing-世界 …
简体中文 登录 BPG Management System F6Publishing-Submit a Manuscript F6Publishing-世界 …
[PDF][PDF] COVID-19 Vaccines (Revisited) and Oral-Mucosal Vector System as a Potential Vaccine Platform. Vaccines 2021, 9, 171
MU Ashraf, Y Kim, S Kumar, D Seo, M Ashraf, YS Bae - 2021 - researchgate.net
There are several emerging strategies for the vaccination of COVID-19 (SARS-CoV-2)
however, only a few have yet shown promising effects. Thus, choosing the right pathway and …
however, only a few have yet shown promising effects. Thus, choosing the right pathway and …